πŸ‡ΊπŸ‡Έ FDA
Patent

US 8999988

Protein kinase inhibitors

granted A61KA61K31/519A61K45/06

Quick answer

US patent 8999988 (Protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/519, A61K45/06, A61P, A61P35/00